Test Price
2,800 AED✅ Home Collection Available
PTH Gene Hypoparathyroidism Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجين PTH لقصور الغدد جارات الدرقية بالتسلسل الجيني المتقدم في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
This advanced NGS-based genetic test delivers comprehensive sequencing of the entire PTH gene to identify pathogenic variants linked to hypoparathyroidism. Processed in our ISO 9001:2015 certified laboratory (Cert: INT/EGQ/2509DA/3139) under DHA-licensed supervision, results are returned within 3–4 weeks with 99.9% diagnostic sensitivity. The service includes hospital-grade cold-chain home collection (8 AM – 11 PM daily), mandatory pre-test genetic counselling, and post-test telephonic clinical guidance to support informed healthcare decisions.
الملخص التنفيذي
يقدم هذا التحليل الجيني المتقدم تقييماً شاملاً لجين PTH المرتبط بقصور الغدد جارات الدرقية باستخدام تقنية التسلسل الجيني من الجيل التالي (NGS)، وبدقة تشخيصية تصل إلى 99.9% عبر مختبر معتمد بمعيار ISO 9001:2015. يضمن هذا الفحص الامتثال الكامل للمرسوم بقانون اتحادي رقم 41 لسنة 2024 (المادة 87) وقانون حماية البيانات الشخصية في الإمارات، مع توفير خدمة سحب الدم المنزلي المعتمدة والاستشارة الوراثية المتكاملة ودعم تفسير النتائج بعد الفحص.
Overview: PTH Gene Hypoparathyroidism Genetic Test
The PTH Gene Hypoparathyroidism Genetic Test is a comprehensive single-gene sequencing assay that examines the entire coding region of the parathyroid hormone (PTH) gene for pathogenic mutations, deletions, and insertions associated with hereditary and idiopathic hypoparathyroidism. يكتشف هذا التحليل الطفرات الجينية المسببة لقصور الغدد جارات الدرقية بدقة عالية. Utilizing Genetic Test identifies both known and novel variants, enabling definitive molecular diagnosis for patients presenting with persistently low parathyroid hormone levels, unexplained hypocalcemia, or a family history suggestive of inherited parathyroid disorders.
| Parameter | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | 99.9% Sensitivity | Full Gene Coverage | ~95% Sensitivity | Targeted Exon Analysis Only |
| Methodology | NGS (Next Generation Sequencing) – LC-MS/MS Validated | Capillary Electrophoresis Sanger Sequencing |
| Variant Detection | SNVs, Indels, CNVs & Novel Variants | Known Point Mutations & Small Indels Only |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Regulatory Compliance | UAE Federal Decree-Law No. 41/2024, CDS 2026, PDPL Compliant | Variable | May Lack UAE-Specific Certifications |
Physician Insight & Clinical Safety Protocol
Clinical Perspective — Dr. PRABHAKAR REDDY (DHA: 61713011), Consultant Endocrinologist: "Genetic testing for PTH gene mutations is a powerful diagnostic tool, yet it must always be interpreted within the full clinical context. A negative NGS result does not exclude all forms of hypoparathyroidism, as autoimmune and acquired etiologies remain significant. I strongly recommend that every patient undergo pre-test genetic counselling and that results be reviewed by a qualified endocrinologist who can correlate molecular findings with serum calcium, phosphate, and PTH levels for a complete diagnostic picture."
⚠ MEDICATION SAFETY NOTICE: Do not discontinue prescribed calcium supplements, vitamin D analogues (calcitriol/alfacalcidol), or recombinant PTH therapy without consulting your treating physician. Abrupt cessation of these medications can precipitate life-threatening hypocalcemic tetany, seizures, or cardiac arrhythmia. This genetic test is a diagnostic adjunct and does not replace ongoing clinical management.
⚕ Patient Safety: Exclusion Criteria & Emergency Red Flags
Exclusion Criteria for Sample Collection
- Severe bleeding diathesis or therapeutic anticoagulation with INR > 3.0 (relative contraindication — requires clinical clearance)
- Inability to provide informed consent due to cognitive impairment without legal guardian authorization
- Minors under 18 years: Mandatory parental or legal guardian consent as per UAE CDS Law 2026 provisions
- Active severe hypocalcemia (corrected serum calcium < 1.9 mmol/L) — stabilize clinically before elective genetic testing
- Known hypersensitivity to latex or antiseptic agents used in phlebotomy (alternative materials available upon request)
🚨 Emergency Red Flags — Seek Immediate Medical Attention
- Tetany: Involuntary muscle cramps, carpopedal spasm, or Chvostek/Trousseau sign positivity
- Laryngospasm: Sudden difficulty breathing, stridor, or voice changes
- Cardiac Symptoms: Palpitations, prolonged QTc interval on ECG, or syncope
- Seizures: New-onset generalized or focal seizures unresponsive to standard anticonvulsants
- Altered Mental Status: Confusion, disorientation, or hallucinations associated with severe hypocalcemia
Compliance Note: This test adheres to UAE Federal Decree-Law No. 41 of 2024 (Article 87), UAE CDS Law 2026 for genetic testing in minors, and UAE Personal Data Protection Law (PDPL) for genomic data privacy. All patient data is encrypted and stored in compliance with MOHAP data sovereignty requirements. Facility License: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Patient FAQ & Clinical Guidance
What is the PTH Gene Hypoparathyroidism Genetic Test, and how does it work?
This advanced genetic test analyzes the entire PTH gene using Genetic Test sequences all coding exons, intron-exon boundaries, and regulatory regions of the parathyroid hormone gene located on chromosome 11p15. DNA is extracted from your blood sample, enriched for target regions, and sequenced at high depth to identify single nucleotide variants (SNVs), small insertions/deletions (indels), and copy number variations (CNVs). Results are interpreted by clinical geneticists against established pathogenic variant databases, providing a definitive molecular diagnosis for hereditary hypoparathyroidism.
يقوم هذا الاختبار الجيني المتقدم بتحليل شامل لجين PTH باستخدام تقنية التسلسل من الجيل التالي للكشف عن الطفرات المسببة لقصور الغدد جارات الدرقية. يتم تفسير النتائج من قبل أخصائيي الوراثة السريرية وفقاً للمعايير العالمية.
Who should consider undergoing this PTH genetic test?
Individuals with persistent unexplained low calcium, undetectable or inappropriately normal PTH levels, family history of parathyroid disorders, or suspected genetic hypoparathyroidism syndromes should consider this test. This includes neonates and children with early-onset hypocalcemic seizures (with parental consent per CDS Law 2026), adults diagnosed with idiopathic hypoparathyroidism after excluding autoimmune causes, and asymptomatic family members of confirmed PTH mutation carriers seeking predictive genetic screening. Endocrinologists, general physicians, and clinical geneticists may also recommend this test as part of a broader endocrine disorder workup.
يُنصح بهذا الفحص للأفراد الذين يعانون من نقص كالسيوم الدم غير المبرر مع مستويات منخفضة من هرمون PTH، أو لديهم تاريخ عائلي لاضطرابات الغدد جارات الدرقية. يتطلب فحص القاصرين موافقة الوالدين وفقاً لقانون CDS 2026.
How is the sample collected, what are the requirements, and when will I receive my results?
A certified phlebotomist collects a standard whole blood sample, extracted DNA, or a single drop of blood on an FTA card during a scheduled home visit between 8 AM and 11 PM daily. Pre- requirements include a mandatory genetic counselling session to document your clinical history and construct a detailed family pedigree chart identifying relatives affected by PTH gene hypoparathyroidism. Fasting is not required. Samples are transported under ISO-certified cold-chain protocols to our laboratory. Results are delivered within 3 to 4 weeks via secure electronic report, with an optional telephonic consultation for result interpretation.
يتم جمع العينة بواسطة أخصائي سحب دم معتمد خلال زيارة منزلية مجدولة، مع جلسة استشارة وراثية إلزامية قبل الفحص لتوثيق التاريخ الطبي ورسم شجرة العائلة. تظهر النتائج خلال 3 إلى 4 أسابيع مع توفير استشارة هاتفية لتفسيرها.
UAE Regulatory Compliance & Laboratory Accreditation
Patient Support & Insurance Verification: WhatsApp +971 54 548 8731 | Available Daily 8 AM – 11 PM
Reviewed by Dr. PRABHAKAR REDDY (DHA: 61713011) | LOINC: 94474-6 | ICD-10-CM: E20.0, E20.8, Z13.228
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians